Metreleptin for treating lipodystrophy

no alternative value could be sourced from the literature. The patient expert explained that people with lipodystrophy with organ damage may also have fertility issues, pain and fatigue, so those should be taken into account in the model. The clinical expert added that, even when including the utility differential of 0.12, there could be other symptoms or factors not accounted for. The committee concluded it was generally satisfied with the approach to include a utility differential to account for symptoms not captured by estimates of utility related to organ damage. Carer utility 4.21 The company recalled that the committee had concerns about how it had modelled carer utility in its previous submission (see section 4.2). In its resubmission, the model also included a utility decrement to account for the burden on carers of -0.0986. This decrement was estimated as the difference between the mean value for carers in the Lipodystrophy Caregiver Burden Survey (done by the company to explore carers experience in the UK) and the general population norm, obtained from the EQ-5D. The committee was satisfied with the company's approach to model carer utility. Number of carers 4.22 The company assumed that each patient had 2 carers. This was
